Aug-08
AUTHORS : Betina Blak (Details for study: CSD EPIC) now works at AstraZeneca, Horizon Place, 600 Capability Green, Luton, Bedfordshire LU1 3LU, UK – Email: betina.blak@astrazeneca.com OR Gillian Hall, Epidemiology Ltd, Grimsdyke House, RavenscroftPark, London EN5 4ND, United Kingdom – Email: gillian.hall@gchall.com
JOURNAL : Pharmacoepidemiology and Drug Safety
REFERENCE: 17(S1):250
DOI : 10.1002/pds.1631